Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Wilms Tumor × regorafenib × Clear all

Sponsor

Conditions

Colorectal Neoplasms 25 Neoplasms 3 Neoplasm Metastasis 3 Gastrointestinal Stromal Tumors 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Gallbladder Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bile Duct Neoplasms 2 Urothelial Cancer (Urinary Bladder, Ureters, or Renal Pelvis Cancer) 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Rhabdomyosarcoma 1 Renal Insufficiency 1 Physician Education 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Noonan Syndrome 6 1 Metastatic Pancreatic Adenocarcinoma 1 Melanoma 1 Liver Neoplasms 1 Liposarcoma 1 Insulinoma 1 Glucagonoma 1

Interventions

X-Rays 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiotherapy 3 Nuclear Medicine Department, Hospital 3 Vincristine 2 Radiation 2 Doxorubicin 2 Dactinomycin 2 Carboplatin 2 Biopsy 2 ulixertinib 1 tipifarnib 1 thymoglobulin 1 tazemetostat 1 selpercatinib 1 sargramostim 1 pembrolizumab 1 palbociclib 1 olaparib 1 lorvotuzumab mertansine 1 larotrectinib 1 glutamic acid diethyl ester 1 etoposide phosphate 1 erdafitinib 1 cixutumumab 1 Vemurafenib 1 Surgical Procedures, Operative 1 Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡